Engineering IgG-Like Bispecific Antibodies—An Overview

Monoclonal antibody therapeutics have proven to be successful treatment options for patients in various indications. Particularly in oncology, therapeutic concepts involving antibodies often rely on the so-called effector functions, such as antibody dependent cellular cytotoxicity (ADCC) and complem...

Descripción completa

Detalles Bibliográficos
Autores principales: Krah, Simon, Kolmar, Harald, Becker, Stefan, Zielonka, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6640676/
https://www.ncbi.nlm.nih.gov/pubmed/31544880
http://dx.doi.org/10.3390/antib7030028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6640676/
https://www.ncbi.nlm.nih.gov/pubmed/31544880
http://dx.doi.org/10.3390/antib7030028

Ejemplares similares